476618-03-8

Basic information

• Product Name: methyl 4-bromo-6-fluoro-1H-indole-2-carboxylate
• Synonyms: methyl 4-bromo-6-fluoro-1H-indole-2-carboxylate
• CAS NO: 476618-03-8
• Molecular Weight: 272.073
• Mol File: 476618-03-8.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: methyl 4-bromo-6-fluoro-1H-indole-2-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 4-bromo-6-fluoro-1H-indole-2-carboxylate(476618-03-8)
• EPA Substance Registry System: methyl 4-bromo-6-fluoro-1H-indole-2-carboxylate(476618-03-8)

Safety Data

• Hazardous Substances Data: 476618-03-8(Hazardous Substances Data)

Upstream product

• 59142-68-6 2-bromo-4-fluorobenzaldehyde 
• 1816-92-8 Methyl azidoacetate 

Downstream Products

• 1024028-53-2 1-benzyl-4-bromo-6-fluoro-1H-indole-2-carboxylic acid methyl ester 

Relevant articles and documents

SUBSTITUTED TRICYCLIC AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME

The present disclosure includes substituted tricyclic amides, or analogues thereof of formula (I) (I), wherein X, Y, ring A, R1, R5, R6 and R7 are as defined herein, and compositions comprising compounds of formula (I) that can be used to treat or prevent hepatitis B virus (HBV) and/or hepatitis D virus (HDV) infections in a patient.

NOVEL 6,7-DIHYDRO-4H-PYRAZOLO[1,5-A]PYRAZINE INDOLE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)

The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for mating the compounds.

NOVEL INDOLE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)

The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.